Stockholm, Sweden

ESTRO 2026

Session

Sunday
May 17
09:00 - 10:00
K2
Gynaecological cancers 2
Asma Sarwar, United Kingdom;
Sophie Espenel, France
Poster Discussions
Clinical
09:00 - 10:00
Oligometastatic Ovarian Cancer: Why the Radiation Oncologist Should Be Involved Sooner—Outcomes Stratified by ESTRO-EORTC Criteria
Donato Pezzulla, Italy
-688
09:00 - 10:00
Quantification of vertebral dose-response and bone preservation in pelvic radiotherapy: prospective evidence from RadBone randomised controlled trial
Artemis Bouzaki, United Kingdom
-2196
09:00 - 10:00
Radiation-induced chronic haemorrhagic cystitis after cervical cancer radiotherapy: temporal course, impact of interventions and cost analysis.
Ranjan Subramani, India
-1648
09:00 - 10:00
From distress to desire: preliminary results of a prospective comparative study on psychological and sexual outcomes in cervical cancer
Loredana Dinapoli, Italy
-2175
09:00 - 10:00
Lumbopelvic bone and muscle doses and incidence of back pain in EMBRACE-II: results from Indian and Danish locally advanced cervical cancer cohorts.
Supriya Chopra, India
-2581
09:00 - 10:00
Image-Guided Reirradiation for Recurrent Non-Endometrial Gynecologic Cancers: A Multi-Institutional Real-World Analysis
Mateusz Bilski, Poland
-664
09:00 - 10:00
ITV-Free Online Adaptive Adjuvant Pelvic Radiotherapy for Endometrial cancer: Feasibility, Dosimetric Advantages, and Early Oncologic Outcomes.
Marcel Fang, Israel
-4119